UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 301

Sortiert nach

S0941: a phase 2 SWOG study of sorafenib and erlotinib in patients with advanced gallbladder carcinoma or cholangiocarcinoma

British journal of cancer, 2014-02, Vol.110 (4), p.882-887

2014

Link zum Volltext

Verfügbarkeit prüfen

Southwest Oncology Group study S0413: a phase II trial of lapatinib (GW572016) as first-line therapy in patients with advanced or metastatic gastric cancer

Annals of oncology, 2011-12, Vol.22 (12), p.2610-2615

2011

Link zum Volltext

Verfügbarkeit prüfen

Assessment of HER2 gene amplification in adenocarcinomas of the stomach or gastroesophageal junction in the INT-0116/SWOG9008 clinical trial

Annals of oncology, 2013-07, Vol.24 (7), p.1754-1761

2013

Link zum Volltext

Verfügbarkeit prüfen

A USA registry of gastrointestinal stromal tumor patients: changes in practice over time and differences between community and academic practices

Annals of oncology, 2011-11, Vol.22 (11), p.2523-2529

2011

Link zum Volltext

Verfügbarkeit prüfen

Higher capecitabine AUC in elderly patients with advanced colorectal cancer (SWOGS0030)

British journal of cancer, 2013-10, Vol.109 (7), p.1744-1749

2013

Link zum Volltext

Verfügbarkeit prüfen

Medical-aid-in-dying use in the US Pacific Northwest

Annals of oncology, 2018-10, Vol.29, p.viii555-viii556

2018

Link zum Volltext

Verfügbarkeit prüfen

Causal modeling of CALGB/SWOG 80405 (Alliance) identifies primary (1°) side-related angiogenic drivers of metastatic colorectal cancer (mCRC)

Annals of oncology, 2018-10, Vol.29 Suppl 8, p.viii152

2018

Link zum Volltext

Verfügbarkeit prüfen

A phase II study of irinotecan with 5-fluorouracil and leucovorin in patients with previously untreated gastric adenocarcinoma

Annals of oncology, 2001-11, Vol.12 (11), p.1575-1580

2001

Link zum Volltext

Verfügbarkeit prüfen

Tyrosine Kinase Inhibitors Significantly Improved Survival Outcomes in Patients with Metastatic Gastrointestinal Stromal Tumour: A Multi-Institutional Cohort Study

Current oncology (Toronto), 2020-06, Vol.27 (3), p.276-282

2020

Link zum Volltext

Verfügbarkeit prüfen

Progress and Infrastructure for Improved Patient Outcomes of the National Cancer Institute Network Groups

Seminars in oncology, 2015-10, Vol.42 (5), p.679-680

2015

Link zum Volltext

Verfügbarkeit prüfen

A double-blind placebo-controlled randomized phase III trial of 5-fluorouracil and leucovorin, plus or minus trimetrexate, in previously untreated patients with advanced colorectal cancer

Annals of oncology, 2002, Vol.13 (1), p.87-91

2002

Link zum Volltext

Verfügbarkeit prüfen

Phase II study of trimetrexate, fluorouracil, and leucovorin for advanced colorectal cancer

Journal of clinical oncology, 1997-03, Vol.15 (3), p.915-920

1997

Link zum Volltext

Verfügbarkeit prüfen

Transcatheter arterial chemoembolization as primary treatment for hepatocellular carcinoma

The American journal of surgery, 1999-05, Vol.177 (5), p.405-410

1999

Link zum Volltext

Verfügbarkeit prüfen

Phase II study of calcitriol-enhanced docetaxel in patients with previously untreated metastatic or locally advanced pancreatic cancer

Investigational new drugs, 2009-08, Vol.27 (4), p.374-378

2009

Link zum Volltext

Verfügbarkeit prüfen

Panitumumab monotherapy compared with cetuximab and irinotecan combination therapy in patients with previously treated KRAS wild-type metastatic colorectal cancer

Current oncology (Toronto), 2013-12, Vol.20 (6), p.326-332

2013

Link zum Volltext

Verfügbarkeit prüfen

Integrated analysis of overall survival in two randomised studies comparing 5-fluorouracil/leucovorin with or without trimetrexate in advanced colorectal cancer

Annals of oncology, 2002-01, Vol.13 (1), p.92-94

2002

Link zum Volltext

Verfügbarkeit prüfen

Topoisomerase I inhibitors in the treatment of colorectal cancer

Seminars in oncology, 1999-12, Vol.26 (6), p.632-639

1999

Link zum Volltext

Verfügbarkeit prüfen

Nonoperative management of primary colorectal cancer in patients with stage IV disease

Annals of surgical oncology, 1999-10, Vol.6 (7), p.651-657

1999

Link zum Volltext

Verfügbarkeit prüfen

Activity of multitargeted antifolate (pemetrexed disodium, LY231514) in patients with advanced colorectal carcinoma : Results from a phase II study

Cancer, 2000-04, Vol.88 (8), p.1807-1813

2000

Link zum Volltext

Verfügbarkeit prüfen

Relation of tumor pathologic and molecular features to outcome after surgical resection of localized primary gastrointestinal stromal tumor (GIST): Results of the intergroup phase III trial ACOSOG Z9001

Journal of clinical oncology, 2010-05, Vol.28 (15_suppl), p.10006-10006

2010

Link zum Volltext

Verfügbarkeit prüfen

Concurrent paclitaxel and thoracic irradiation for locally advanced esophageal cancer

Seminars in radiation oncology, 1999-04, Vol.9 (2 Suppl 1), p.43

1999

Link zum Volltext

Verfügbarkeit prüfen

Two or three year disease-free survival (DFS) as a primary end-point in stage III adjuvant colon cancer trials with fluoropyrimidines with or without oxaliplatin or irinotecan: Data from 12,676 patients from MOSAIC, X-ACT, PETACC-3, C-06, C-07 and C89803

European journal of cancer (1990), 2011-05, Vol.47 (7), p.990-996

2011

Link zum Volltext

Verfügbarkeit prüfen

Disease-Free Survival Versus Overall Survival As a Primary End Point for Adjuvant Colon Cancer Studies: Individual Patient Data From 20,898 Patients on 18 Randomized Trials

Journal of clinical oncology, 2005-12, Vol.23 (34), p.8664-8670

2005

Link zum Volltext

Verfügbarkeit prüfen

Kinase Mutations and Imatinib Response in Patients With Metastatic Gastrointestinal Stromal Tumor

Journal of clinical oncology, 2003-12, Vol.21 (23), p.4342-4349

2003

Link zum Volltext

Verfügbarkeit prüfen

Inhibition of KIT tyrosine kinase activity: A novel molecular approach to the treatment of KIT-positive malignancies

Journal of clinical oncology, 2002-03, Vol.20 (6), p.1692-1703

2002

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 301

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(275)
Mit Volltextzugriff
(278)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(146)
Life Sciences & Biomedicine
(132)
Humans
(127)
Oncology
(75)
Female
(73)
Male
(68)
Middle Aged
(56)
Aged
(55)
Biological And Medical Sciences
(50)
Adult
(43)
Medical Sciences
(42)
Aged, 80 And Over
(31)
Tumors
(30)
Treatment Outcome
(29)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(24)
Chemotherapy
(24)
Animals
(20)
Gastroenterology. Liver. Pancreas. Abdomen
(20)
Imatinib Mesylate
(19)
Antineoplastic Agents - Therapeutic Use
(18)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

S0941: a phase 2 SWOG study of sorafenib and erlotinib in patients with advanced gallbladder carcinoma or cholangiocarcinoma

Southwest Oncology Group study S0413: a phase II trial of lapatinib (GW572016) as first-line therapy in patients with advanced or metastatic gastric cancer

Assessment of HER2 gene amplification in adenocarcinomas of the stomach or gastroesophageal junction in the INT-0116/SWOG9008 clinical trial

A USA registry of gastrointestinal stromal tumor patients: changes in practice over time and differences between community and academic practices

Higher capecitabine AUC in elderly patients with advanced colorectal cancer (SWOGS0030)

Medical-aid-in-dying use in the US Pacific Northwest

Causal modeling of CALGB/SWOG 80405 (Alliance) identifies primary (1°) side-related angiogenic drivers of metastatic colorectal cancer (mCRC)

A phase II study of irinotecan with 5-fluorouracil and leucovorin in patients with previously untreated gastric adenocarcinoma

Tyrosine Kinase Inhibitors Significantly Improved Survival Outcomes in Patients with Metastatic Gastrointestinal Stromal Tumour: A Multi-Institutional Cohort Study

Progress and Infrastructure for Improved Patient Outcomes of the National Cancer Institute Network Groups

A double-blind placebo-controlled randomized phase III trial of 5-fluorouracil and leucovorin, plus or minus trimetrexate, in previously untreated patients with advanced colorectal cancer

Phase II study of trimetrexate, fluorouracil, and leucovorin for advanced colorectal cancer

Transcatheter arterial chemoembolization as primary treatment for hepatocellular carcinoma

Phase II study of calcitriol-enhanced docetaxel in patients with previously untreated metastatic or locally advanced pancreatic cancer

Panitumumab monotherapy compared with cetuximab and irinotecan combination therapy in patients with previously treated KRAS wild-type metastatic colorectal cancer

Integrated analysis of overall survival in two randomised studies comparing 5-fluorouracil/leucovorin with or without trimetrexate in advanced colorectal cancer

Topoisomerase I inhibitors in the treatment of colorectal cancer

Nonoperative management of primary colorectal cancer in patients with stage IV disease

Activity of multitargeted antifolate (pemetrexed disodium, LY231514) in patients with advanced colorectal carcinoma : Results from a phase II study

Relation of tumor pathologic and molecular features to outcome after surgical resection of localized primary gastrointestinal stromal tumor (GIST): Results of the intergroup phase III trial ACOSOG Z9001

Concurrent paclitaxel and thoracic irradiation for locally advanced esophageal cancer

Two or three year disease-free survival (DFS) as a primary end-point in stage III adjuvant colon cancer trials with fluoropyrimidines with or without oxaliplatin or irinotecan: Data from 12,676 patients from MOSAIC, X-ACT, PETACC-3, C-06, C-07 and C89803

Disease-Free Survival Versus Overall Survival As a Primary End Point for Adjuvant Colon Cancer Studies: Individual Patient Data From 20,898 Patients on 18 Randomized Trials

Kinase Mutations and Imatinib Response in Patients With Metastatic Gastrointestinal Stromal Tumor

Inhibition of KIT tyrosine kinase activity: A novel molecular approach to the treatment of KIT-positive malignancies

Suchergebnisse filtern